An official American Thoracic Society/American College of Chest Physicians policy statement

Implementation of low-dose computed tomography lung cancer screening programs in clinical practice

ATS/CHEST Committee on Low-Dose CT Lung Cancer Screening in Clinical Practice

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

Rationale: Annual low-radiation-dose computed tomography (LDCT) screening for lung cancer has been shown to reduce lung cancer mortality among high-risk individuals and is now recommended bymultiple organizations. However, LDCT screening is complex, and implementation requires careful planning to ensure benefits outweigh harms. Little guidance has been provided for sites wishing to develop and implement lung cancer screening programs. Objectives: To promote successful implementation of comprehensive LDCT screening programs that are safe, effective, and sustainable. Methods: The American Thoracic Society (ATS) and American College of Chest Physicians (CHEST) convened a committee with expertise in lung cancer screening, pulmonary nodule evaluation, and implementation science. The committee reviewed the evidence from systematic reviews, clinical practice guidelines, surveys, and the experience of early-adopting LDCT screening programs and summarized potential strategies to implement LDCT screening programs successfully. Measurements and Main Results: We address steps that sites should consider during the main three phases of developing anLDCT screening program: planning, implementation, and maintenance. We present multiple strategies to implement the nine core elements of comprehensive lung cancer screening programs enumerated in a recent CHEST/ATS statement, which will allow sites to select the strategy that best fits with their local context and workflow patterns. Although we do not comment on cost-effectiveness of LDCT screening, we outline the necessary costs associated with starting and sustaining a high-quality LDCT screening program. Conclusions: Following the strategies delineated in this policy statement may help sites to develop comprehensive LDCT screening programs that are safe and effective.

Original languageEnglish (US)
Pages (from-to)881-891
Number of pages11
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume192
Issue number7
DOIs
StatePublished - Oct 1 2015

Fingerprint

Early Detection of Cancer
Lung Neoplasms
Tomography
Radiation
Workflow
Practice Guidelines
Cost-Benefit Analysis
Thorax
Maintenance
Organizations
Costs and Cost Analysis
Lung
Mortality

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

An official American Thoracic Society/American College of Chest Physicians policy statement : Implementation of low-dose computed tomography lung cancer screening programs in clinical practice. / ATS/CHEST Committee on Low-Dose CT Lung Cancer Screening in Clinical Practice.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 192, No. 7, 01.10.2015, p. 881-891.

Research output: Contribution to journalArticle

@article{2b306030f60c4654a8128169f9dac15b,
title = "An official American Thoracic Society/American College of Chest Physicians policy statement: Implementation of low-dose computed tomography lung cancer screening programs in clinical practice",
abstract = "Rationale: Annual low-radiation-dose computed tomography (LDCT) screening for lung cancer has been shown to reduce lung cancer mortality among high-risk individuals and is now recommended bymultiple organizations. However, LDCT screening is complex, and implementation requires careful planning to ensure benefits outweigh harms. Little guidance has been provided for sites wishing to develop and implement lung cancer screening programs. Objectives: To promote successful implementation of comprehensive LDCT screening programs that are safe, effective, and sustainable. Methods: The American Thoracic Society (ATS) and American College of Chest Physicians (CHEST) convened a committee with expertise in lung cancer screening, pulmonary nodule evaluation, and implementation science. The committee reviewed the evidence from systematic reviews, clinical practice guidelines, surveys, and the experience of early-adopting LDCT screening programs and summarized potential strategies to implement LDCT screening programs successfully. Measurements and Main Results: We address steps that sites should consider during the main three phases of developing anLDCT screening program: planning, implementation, and maintenance. We present multiple strategies to implement the nine core elements of comprehensive lung cancer screening programs enumerated in a recent CHEST/ATS statement, which will allow sites to select the strategy that best fits with their local context and workflow patterns. Although we do not comment on cost-effectiveness of LDCT screening, we outline the necessary costs associated with starting and sustaining a high-quality LDCT screening program. Conclusions: Following the strategies delineated in this policy statement may help sites to develop comprehensive LDCT screening programs that are safe and effective.",
author = "{ATS/CHEST Committee on Low-Dose CT Lung Cancer Screening in Clinical Practice} and Wiener, {Renda Soylemez} and Gould, {Michael K.} and Arenberg, {Douglas A.} and Au, {David H.} and Kathleen Fennig and Lamb, {Carla R.} and Mazzone, {Peter J.} and Midthun, {David Eric} and Maryann Napoli and Ost, {David E.} and Powell, {Charles A.} and Rivera, {M. Patricia} and Slatore, {Christopher G.} and Tanner, {Nichole T.} and Anil Vachani and Wisnivesky, {Juan P.} and Yoon, {Sue H.} and Black, {William C.} and Frank Detterbeck and Edward Hirschowitz and James Jett and Linda Kinsinger",
year = "2015",
month = "10",
day = "1",
doi = "10.1164/rccm.201508-1671ST",
language = "English (US)",
volume = "192",
pages = "881--891",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "7",

}

TY - JOUR

T1 - An official American Thoracic Society/American College of Chest Physicians policy statement

T2 - Implementation of low-dose computed tomography lung cancer screening programs in clinical practice

AU - ATS/CHEST Committee on Low-Dose CT Lung Cancer Screening in Clinical Practice

AU - Wiener, Renda Soylemez

AU - Gould, Michael K.

AU - Arenberg, Douglas A.

AU - Au, David H.

AU - Fennig, Kathleen

AU - Lamb, Carla R.

AU - Mazzone, Peter J.

AU - Midthun, David Eric

AU - Napoli, Maryann

AU - Ost, David E.

AU - Powell, Charles A.

AU - Rivera, M. Patricia

AU - Slatore, Christopher G.

AU - Tanner, Nichole T.

AU - Vachani, Anil

AU - Wisnivesky, Juan P.

AU - Yoon, Sue H.

AU - Black, William C.

AU - Detterbeck, Frank

AU - Hirschowitz, Edward

AU - Jett, James

AU - Kinsinger, Linda

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Rationale: Annual low-radiation-dose computed tomography (LDCT) screening for lung cancer has been shown to reduce lung cancer mortality among high-risk individuals and is now recommended bymultiple organizations. However, LDCT screening is complex, and implementation requires careful planning to ensure benefits outweigh harms. Little guidance has been provided for sites wishing to develop and implement lung cancer screening programs. Objectives: To promote successful implementation of comprehensive LDCT screening programs that are safe, effective, and sustainable. Methods: The American Thoracic Society (ATS) and American College of Chest Physicians (CHEST) convened a committee with expertise in lung cancer screening, pulmonary nodule evaluation, and implementation science. The committee reviewed the evidence from systematic reviews, clinical practice guidelines, surveys, and the experience of early-adopting LDCT screening programs and summarized potential strategies to implement LDCT screening programs successfully. Measurements and Main Results: We address steps that sites should consider during the main three phases of developing anLDCT screening program: planning, implementation, and maintenance. We present multiple strategies to implement the nine core elements of comprehensive lung cancer screening programs enumerated in a recent CHEST/ATS statement, which will allow sites to select the strategy that best fits with their local context and workflow patterns. Although we do not comment on cost-effectiveness of LDCT screening, we outline the necessary costs associated with starting and sustaining a high-quality LDCT screening program. Conclusions: Following the strategies delineated in this policy statement may help sites to develop comprehensive LDCT screening programs that are safe and effective.

AB - Rationale: Annual low-radiation-dose computed tomography (LDCT) screening for lung cancer has been shown to reduce lung cancer mortality among high-risk individuals and is now recommended bymultiple organizations. However, LDCT screening is complex, and implementation requires careful planning to ensure benefits outweigh harms. Little guidance has been provided for sites wishing to develop and implement lung cancer screening programs. Objectives: To promote successful implementation of comprehensive LDCT screening programs that are safe, effective, and sustainable. Methods: The American Thoracic Society (ATS) and American College of Chest Physicians (CHEST) convened a committee with expertise in lung cancer screening, pulmonary nodule evaluation, and implementation science. The committee reviewed the evidence from systematic reviews, clinical practice guidelines, surveys, and the experience of early-adopting LDCT screening programs and summarized potential strategies to implement LDCT screening programs successfully. Measurements and Main Results: We address steps that sites should consider during the main three phases of developing anLDCT screening program: planning, implementation, and maintenance. We present multiple strategies to implement the nine core elements of comprehensive lung cancer screening programs enumerated in a recent CHEST/ATS statement, which will allow sites to select the strategy that best fits with their local context and workflow patterns. Although we do not comment on cost-effectiveness of LDCT screening, we outline the necessary costs associated with starting and sustaining a high-quality LDCT screening program. Conclusions: Following the strategies delineated in this policy statement may help sites to develop comprehensive LDCT screening programs that are safe and effective.

UR - http://www.scopus.com/inward/record.url?scp=84943262834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943262834&partnerID=8YFLogxK

U2 - 10.1164/rccm.201508-1671ST

DO - 10.1164/rccm.201508-1671ST

M3 - Article

VL - 192

SP - 881

EP - 891

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 7

ER -